A 26-year-old man has gone on trial at the Central Criminal Court in Cork charged with the murder of a man in Mallow in July 2018.
Tyler Jackson, who has an address in Mallow, has pleaded not guilty to the charge of murdering Conor Quinn at Bridge Street in the town.
The court was told that Mr Quinn died of a single stab wound to the chest.
Mr Quinn was originally from Loughrea in Co Galway and grew up in Tipperary town. He was 24 and had been living in the North Cork village of Kilavullen.
Opening the prosecution's case to the jury of four women and eight men, senior counsel Ray Boland said Mr Quinn and Mr Jackson were known to each other. The court heard there was some animosity between them, and they were not friends.
Mr Boland said Conor Quinn had returned to Mallow to get food on the evening of 12 July 2018, having attended Cahirmee Fair in Buttevant with his cousins and a friend earlier in the day.
He said there were two confrontations around 40 minutes apart between Mr Quinn and Mr Jackson.
The first occurred on Main Street at around 8pm, which ended when Mr Jackson left the scene.
He said the second occurred on Bridge Street at 8.38pm, when Mr Quinn was in a car and spotted Mr Jackson on the street. He said Mr Quinn got out of the car and there was a physical confrontation, described as a scuffle, between the two men on the street.
He said Mr Jackson struck Mr Quinn once in the chest and ran away.
Mr Boland said it was the prosecution's case that that strike was with a knife, resulting in a stab wound from which Mr Quinn died.
He said Mr Quinn went back to his friends and said: "He's after stabbing me".
Mr Boland said that, by coincidence, there was an ambulance on the street and Mr Quinn sought medical assistance but, within a minute or two, he collapsed.
He said he never regained consciousness and died.
He said the Assistant State Pathologist Dr Margot Bolster conducted a post-mortem examination on Mr Quinn's body, and the cause of death was given as haemorrhage and shock resulting from a single stab wound to the chest.
The trial is continuing and is expected to last for two weeks.
